Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07303725 · ClinicalTrials.gov registry record
Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology
A clinical trial of Renal Cancer and Liver Cancer (Primary and Metastatic), sponsored by Palo Alto Veterans Institute for Research.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT07303725: Recruiting study of Renal Cancer and Liver Cancer (Primary and Metastatic), sponsored by Palo Alto Veterans Institute for Research.
NCT07303725 is a study of Renal Cancer and Liver Cancer (Primary and Metastatic) that is actively recruiting participants, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 30 participants, below the 609-participant average among 29 other Renal Cancer trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07303725, a study of Renal Cancer and Liver Cancer (Primary and Metastatic), is actively recruiting participants, sponsored by Palo Alto Veterans Institute for Research.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study to evaluate the feasibility, image quality, and procedural utility of a novel spectral CT technique using Canon Medical's 4D CT system during image-guided interventional oncology procedures
Primary Outcome
Effective Dose and CTDI
Conditions Studied
Study Locations (1)
California
- VA Palo Alto Healthcare System - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2026-09-01 |
What NCT07303725 shows while recruiting
NCT07303725 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 609-participant average among 29 other Renal Cancer trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Renal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT07303725 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07303725 about?
NCT07303725 is a clinical study titled "Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology". This is a pilot study to evaluate the feasibility, image quality, and procedural utility of a novel spectral CT technique using Canon Medical's 4D CT system during image-guided interventional oncology procedures
What is the current status of trial NCT07303725?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-02-01. Estimated completion is 2026-09-01.
What conditions does trial NCT07303725 study?
This clinical trial studies the following conditions: Renal Cancer, Liver Cancer (Primary and Metastatic).
Who is sponsoring clinical trial NCT07303725?
This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07303725 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07303725's enrollment target sits among peer trials
30 26th of 29 higher than 3 of 29 other Renal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Renal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Kidney Cancer DNA Registry
RECRUITING
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RECRUITING
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
RECRUITING · Phase 1
-
Advanced Diffusion Imaging in Renal Cancer Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI